Next, we investigated two human PCa cohorts (The Cancer Genome Atlas (TCGA) and SU2C) and hypothesized that reduced sensitivity to AR-targeted therapy would correlate with a higher frequency of copy number variations of JAK–STAT genes in mCRPC tumors than in hormone-sensitive primary tumors50–52. Here, AR is linked to posterior cortical atrophy.